Medications can be dosed in various formats, allowing customization by personal volume and adapting to pediatric and geriatric use.
The National University of Córdoba, as part of the “Science in Action” program, presented a 3D printer for medication production in Córdoba, recognized by the 2023 Innovar Award. This breakthrough will allow medication dosing according to each patient’s body volume and adaptation to different forms and sizes for pediatric and geriatric applications.
Researchers from UNC and Conicet have created a 3D printing platform to produce a wide variety of forms and doses tailored to each patient’s needs.
Santiago Palma, Secretary of Innovation and Technological Engagement at the National University of Córdoba, commented to Cadena 3 that “the personalization of pharmacotherapy is essential and was a technological challenge that the 3D printer now makes possible.”
Juan Pablo Real, Daniel Real, and Enzo Moriconi are the creators of this groundbreaking invention, which could revolutionize the pharmaceutical market.
“Just as Nespresso brought café-bar quality coffee into homes, we bring the printer and materials to pharmacies, enabling personalization,” highlighted Daniel Real, one of the inventors.
The product, already patented, has been sold to Chile and Ecuador, with Paraguay next in line, and there are plans to patent it in the United States.
“This printer has an advantage over traditional 3D printers that melt filaments at 190°C; ours can operate at 40°C, expanding the range of molecules that can be incorporated, such as proteins for biological medications,” added Real.
The goal is to counter the traditional concept of standardized remedies in pharmacies. This printer creates each medication tailored to patients’ needs and body types, with capsule dimensions and concentration levels adjusted so multiple medications can be combined into one pill if needed.
The goal is to counter the traditional concept of standardized remedies in pharmacies. This printer creates each medication tailored to patients’ needs and body types, with capsule dimensions and concentration levels adjusted so multiple medications can be combined into one pill if needed.
Palma also emphasized that “this is a tech-driven university,” and the concept is intellectually protected, with aims to expand. “It helps us improve quality of life and adapt medications to optimize usage and criteria.”
The University hopes to shift the current paradigm, envisioning a future where pharmacists load the cartridge without powder or solvents, and the product is ready for consumption once printed.
Interview from “Viva la Radio”
